Open Terminal →

Analyses / NKE

NKE NIKE, Inc. As of Nov 19, 2026
$36.31

Near 52-week lows at 17x earnings, but revenue and EPS are shrinking. Data gaps limit conviction.

Setup: Recovery watch (value with negative growth) Confidence: low Horizon: 3-6 months Risk: elevated Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals NKE's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

If the turnaround stabilizes sales, the stock may re-rate from its low P/E (17.3x trailing, 17.3x forward). Price sits about 12% above its 52-week low of $31.97 and 45% below the high of $69.14, so a recovery could be sharp. Insider share flow was net positive in the provider data (28.7M shares bought vs 22.3M sold). Current ratio of 1.96 suggests near-term liquidity is adequate. Dividend yield is 1.37%.

▼ Bear Case

Revenue growth is -3.24% and EPS growth is -13.39% (5-year EPS growth -10.02%), so the cheap multiple may reflect falling earnings. Recent headlines describe the investor day outlook as disappointing. Payout ratio of 77.45% leaves limited room for dividend growth if earnings keep falling. Net margin of 6.7% and operating margin of 8.18% are thin. Price-to-book of 4.58x is high relative to tangible book of $9.86 per share.

Valuation

Cheap on earnings, weak on growth — score 55/100

Low trailing and forward P/E against falling EPS. Price-to-book is high versus tangible book, so asset backing is thin.

Technical Levels

Support · $34.96 (Intraday day low) · $31.97 (52-week low)

Resistance · $36.88 (Intraday day high) · $40.00 (Target level (analyst scenario, not a provider level))

RSI: RSI not available in payload

Financial Health

Score 60/100. Liquidity ratios are adequate. Leverage and interest coverage are not in the payload, so the balance sheet read is incomplete.

Catalysts

Investor day outlook follow-up and any revised guidanceNext earnings report (date not in payload)high
Whether revenue decline rate narrowsNext two quarterly reportshigh
Dividend coverage as payout ratio stays near 77%Next dividend declarationmedium

Risk Flags

Revenue growth -3.24% and EPS growth -13.39% in provider data.
Payout ratio 77.45% limits dividend cushion if earnings decline continues.
RSI, ROE, ROIC, debt-to-equity, PEG and FCF per share are null in the payload.
Fundamentals, balance sheet, cash flow and sentiment objects are null, so coverage is thin.
Price sits 11.7% above the 52-week low; a close below $31.97 would break the range.
Provider news flow is negative in tone (outlook disappointment, bearish analyst notes).

See NKE's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock NKE free →

Recent News

More Analyses

NKE FAQ

Is NKE a buy right now?

NIKE, Inc.'s current read is a Recovery watch (value with negative growth) setup with low confidence over a 3-6 months horizon. Valuation: Cheap on earnings, weak on growth. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is NKE overvalued?

Cheap on earnings, weak on growth (valuation score 55/100). Low trailing and forward P/E against falling EPS. Price-to-book is high versus tangible book, so asset backing is thin.

What are the risks of buying NKE?

Revenue growth is -3.24% and EPS growth is -13.39% (5-year EPS growth -10.02%), so the cheap multiple may reflect falling earnings. Recent headlines describe the investor day outlook as disappointing. Payout ratio of 77.45% leaves limited room for dividend growth if earnings keep falling. Net margin of 6.7% and operating margin of 8.18% are thin. Price-to-book of 4.58x is high relative to tangible book of $9.86 per share.